Evidence map›Paper›PMID 32028621›Full record

ArticleMolecules (Basel, Switzerland)2020

Wafaa M Elkady, Iriny M Ayoub, Yousra Abdel-Mottaleb, Mohamed F ElShafie, Michael Wink

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Valorization ofMolecules (Basel, Switzerland) · 2022
    Article
  8. Chemical Profile ofMolecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Wafaa M ElkadyDepartment of Pharmacognosy, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt, New Cairo 11835, Egypt.ORCID 0000-0002-7656-3892
Iriny M AyoubDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0003-2382-8241
Yousra Abdel-MottalebDepartment of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University in Egypt, New Cairo 11835, Egypt.ORCID 0000-0002-4327-4920
Mohamed F ElShafieDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt.
Michael WinkInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, INF 364, D-69120 Heidelberg, Germany.ORCID 0000-0002-7875-4510
Future University in Egypt · EGAin Shams University · EGHeidelberg University · DESinai University · EG

Funding

Science and Technology Development Fund 25448
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, PhytogenicAsteraceaeATP Binding Cassette Transporter, Subfamily B, Member 1Cell Line, TumorCell SurvivalChromatography, High Pressure LiquidDose-Response Relationship, DrugFlowersHumansModels, MolecularMolecular ConformationPhytochemicalsPlant ExtractsSpectrometry, Mass, Electrospray IonizationStructure-Activity RelationshipTandem Mass SpectrometryAntineoplastic Agents, PhytogenicATP Binding Cassette Transporter, Subfamily B, Member 1PhytochemicalsPlant ExtractsbromodomainscytotoxicityEuryops pectinatusLC/MSmolecular dockingmultidrug resistanceP-glycoprotein

Identifiers

PMID32028621
PMCPMC7038149
OpenAlexW3004413061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.